Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials
Publication year
2020Source
Cancers, 12, 11, (2020), article 3334ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Human Genetics
Haematology
Tumorimmunology
Journal title
Cancers
Volume
vol. 12
Issue
iss. 11
Subject
Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Haematology - Radboud University Medical Center; Human Genetics - Radboud University Medical Center; Radboud University Medical Center; Tumorimmunology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [244262]
- Electronic publications [131246]
- Faculty of Medical Sciences [92892]
- Open Access publications [105260]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.